Ascend Wellness Holdings (AAWH) Income from Continuing Operations (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Income from Continuing Operations of 29493000.0 for Q1 2026, down 53.15% year-over-year from 62947599.91 in Q1 2025, and up 39.44% quarter-over-quarter from 48703000.0 in Q4 2025.
Ascend Wellness Holdings (AAWH) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 29493000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 53.15% year-over-year to 29493000.0; the TTM figure through Mar 2026 stood at 128428000.0 (down 49.18% YoY), while the FY2025 annual figure was 118193000.0, down 39.06% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 29493000.0, up from 48703000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 841000.0 in Q2 2023, with the low at 48703000.0 in Q4 2025.
- The 5-year median for Income from Continuing Operations is 19343000.0 (2023), against an average of 21281941.18.
- The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations jumped 103.97% in 2023, then tumbled 2690.25% in 2024.
- Ascend Wellness Holdings' Income from Continuing Operations stood at 15050000.0 in 2022, then decreased by 28.52% to 19343000.0 in 2023, then gained by 13.19% to 16791000.0 in 2024, then sank by 190.05% to 48703000.0 in 2025, then soared by 39.44% to 29493000.0 in 2026.
- Business Quant data shows AAWH's Income from Continuing Operations at 29493000.0 in Q1 2026, 48703000.0 in Q4 2025, and 25825000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Ascend Wellness Holdings | 97.42 Mn | 30.42 Mn | 45.49 Mn | -9.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.81 Mn |
| Mar 31, 2026 | -29.49 Mn |
| Dec 31, 2025 | -48.70 Mn |
| Sep 30, 2025 | -25.83 Mn |
| Jun 30, 2025 | -24.41 Mn |
| Mar 31, 2025 | -19.26 Mn |
| Dec 31, 2024 | -16.79 Mn |
| Sep 30, 2024 | -28.26 Mn |
| Jun 30, 2024 | -21.78 Mn |
| Mar 31, 2024 | -18.16 Mn |
| Dec 31, 2023 | -19.34 Mn |
| Sep 30, 2023 | -11.24 Mn |
| Jun 30, 2023 | 841,000.00 |
| Mar 31, 2023 | -18.47 Mn |
| Dec 31, 2022 | -15.05 Mn |
| Sep 30, 2022 | -16.86 Mn |
| Jun 30, 2022 | -21.17 Mn |
| Mar 31, 2022 | -27.82 Mn |
| Dec 31, 2021 | -16.51 Mn |
| Sep 30, 2021 | -13.03 Mn |